Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Upper Lid Retraction in Thyroid Eye Disease
NCT00370734Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in thyroid eye disease (TED), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT00370734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370734.